F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding F-star Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 43 | 40 | −3 |
| Shares | 10.6M | 8.18M | −2.42M (−22.9%) |
| Value | $53.2M | $29.0M | −$24.2M (−45.5%) |
New holders (7)
Institutions that held F-star Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 75,190 | $267.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 54,981 | $194.4K | 0.00% |
| Goldman Sachs Group Inc | 33,802 | $120.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 15,865 | $56.0K | 0.00% |
| Envestnet Asset Management Inc | 13,564 | $48.0K | 0.00% |
| Marshall Wace, LLP | 10,456 | $37.0K | 0.00% |
| Bank of America Corp | 162 | $1.00K | 0.00% |
Sold out (10)
Institutions that held F-star Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Ridgeback Capital Investments L.P. | 1,834,360 | $9.21M |
| Janus Henderson Group PLC | 522,158 | $2.63M |
| Truist Financial Corp | 79,092 | $397.0K |
| Eversept Partners, LP | 49,933 | $250.7K |
| Susquehanna International Group, LLP | 14,251 | $72.0K |
| Engineers Gate Manager LP | 10,700 | $54.0K |
| ExodusPoint Capital Management, LP | 10,854 | $54.0K |
| Total Clarity Wealth Management, Inc. | 3,500 | $18.0K |
| Arcadia Investment Management Corp | 3,000 | $15.0K |
| Simplex Trading, LLC | 2,366 | $11.0K |